Coalition urges Congress to reject harmful bill removing oversight review process currently used to protect against Big Pharma’s rampant patent abuse leading to significant higher prescription drug prices for patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the […]

Continue Reading

Applauds Senators Cornyn and Blumenthal for their efforts to stop the major drug companies from abusing the U.S. patent system to delay or prevent patients from accessing more affordable generic alternative medications and treatments. WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading

Study Finds Average Annual Cost For Specialty Drugs Climbed To Almost $79,000 In 2017 WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the following statement today in response to a new AARP report which found that the average […]

Continue Reading

Coalition thanks Representatives Jeffries, Collins, Mucarsel-Powell and Cline for introducing TERM Act, to stop major drug companies from using patent thickets to prevent affordable generic drugs and treatments from reaching American consumers WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and […]

Continue Reading

Good afternoon – In case you missed it, after several days of stinging testimony and growing public blowback against their proposed legislation that would overrule over 150 years of carefully crafted Supreme Court precedent on patent eligibility and open the floodgates to further abuses of the patent system by Big Pharma, Senators Tillis and Coons […]

Continue Reading

Coalition calls on Senators Tillis and Coons to amend their draft legislation and protect significant Supreme Court rulings on patents that restrict abuse by Big Pharma Click here to read CAPA’s full letter to Congress urging opposition to Tillis/Coons legislation WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, […]

Continue Reading

Coalition calls on Congress to oppose “poison pill” bill that would undo significant Supreme Court rulings on patent abuse and ultimately lead to increased prescription drug prices and reduced access to life-saving treatments   WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market […]

Continue Reading

  COALITION AGAINST PATENT ABUSE (CAPA) FORMS TO LOWER DRUG PRICES BY ENDING BRAND NAME DRUG PATENT ABUSE Consumer groups, patients, free market advocacy organizations and health care industry associations band together to advocate for policies to end overextended brand drug monopolies Washington, DC (January 16, 2019) Healthcare providers, free market advocates, consumer groups, patient […]

Continue Reading